'HAL Allergy is among the leading European firms that specialize in the development, production, and distribution of allergen immunotherapies used in treating and preventing allergic diseases. The company boasts a competitive range of products, featuring subcutaneous and sublingual items. Always looking forward, HAL Allergy maintains a pipeline portfolio, showing commitment to consistently provide top-tier medical products and scientific results. The company is headquartered in the Bio Science Park in Leiden, The Netherlands.'